

          -  ALT / AST> 5 times the normal limit

          -  Stage 4 chronic kidney disease (GFR <30) or requiring dialysis.

          -  Presence of comorbidities that imply a poor prognosis (according to clinical
             judgment).

          -  Advanced dementia.

          -  Pregnancy or breastfeeding.

          -  Anticipation of transfer to another center in the 12 hours at the beginning of the
             study.

          -  Allergy to study medication.

          -  Serious or active bacterial infections or documented sepsis by pathogens other than
             SARS-CoV-2.

          -  Streptococcus pneumoniae antigenuria positive before study start.

          -  Neutropenia <500 / mm3.

          -  Thrombocytopenia <100,000 / mm3.

          -  History of diverticulosis.

          -  Ongoing skin infection (eg, pyodermitis).

          -  Transplanted patient under immunosuppressive treatment.

          -  Previous evidence of latent untreated tuberculosis.
      